Summary

この調査レポートはスマートピル市場を詳細に調査・分析し、2026年までの市場予測を行っています。

Overview

This report evaluates the smart pills market including the technologies, companies, and solutions for smart pill delivery, monitoring, and diagnostics. The report assesses the impact of smart pills themselves as well as supporting technologies such as IoT, AI, and data analytics.

This report also investigates the use of 3D printing for smart drug delivery, facilitating medical diagnostics on-demand. The report also evaluates the smart pill market by distribution channel including hospitals, clinics, research institutes, and home healthcare delivery.

Smart pill applications investigated include imaging, sensing and other diagnostic methods as well as ongoing health monitoring and analysis. Smart pill technologies evaluated include those required for endoscopy as well as gastrointestinal monitoring in general.

Additional technologies evaluated include smart pill related data storage and analytics software. The report includes forecasts for 2021 ? 2026 analyzing the market outlook and opportunities for smart pills globally and regionally.

Select Report Findings:

• The global smart pill market as a whole will reach $6.34 billion by 2026, growing by 18% CAGR
• North America is the largest region, followed by Asia Pacific and Europe through the study period
• Tools and technologies in support of smart pills will reach $2.9 billion by 2026, growing by 23% CAGR
• The market for smart pill related data storage and analytics software will reach $437 million globally by 2026, growing at 28% CAGR
• Hospitals and clinics remain the largest distribution channel, but home healthcare is growing more rapidly than any other segment
• Patient diagnostics remains the largest application area through 2026 and is anticipated to remain dominant through the study period

Medical Technology (MedTech) is poised to benefit greatly from the convergence of Internet of Things (IoT) technologies including machine-to-machine communications, smart micro or nano-sensors, and other IoT components. Smart pills represent a significant area for next generation MedTech diagnostic solutions in which ingestible tablets or capsules embedded with sensor, camera, tracker, or microchip are swallowed by a person for purposes of obtaining physiological status and activities.

Combined with IoT, smart pills allow for data capture and monitoring of the subject, regardless of their location. Mind Commerce sees substantial implications for various remote healthcare applications including endoscopy, gastrointestinal monitoring in general, as well as other investigative procedures that would otherwise be more invasive, expensive, and time consuming for the patient. Coupled with next generation data analytics, healthcare practitioners may leverage these MedTech solutions to provide diagnostics to virtually anyone, anywhere on a substantially lower cost basis.

Since Mind Commerce coverage of this market began four years ago, we have identified an additional substantial market driver for smart pills in the wake of the COVID-19 pandemic. We see the need to monitor otherwise healthy people on an ongoing basis due the substantial amount of disinfectant in the ambient environment.

This is because the gut biome may be impacted by disinfectants due die-off of beneficial bacteria in the digestive system of humans. This is especially a concern with particularly sensitive individuals. Accordingly, Mind Commerce sees a market driver in terms of monitoring gut health to provide general analytics as well as to identify triggers for the need to apply mediation measures such as the consumption of prebiotics and probiotics to ensure proper gut health.

Companies in Report:

• AdhereTech Inc.
• Bio-Images Drug Delivery Limited
• Boston Scientific Corporation
• CapsoVision Inc.
• Cerner Corporation
• Fujifilm Holdings Corporation
• GE Healthcare
• HOYA Corporation
• IntroMedic Co. Ltd.
• Jinshan Science & Technology (Group) Co. Ltd.
• Koninklijke Philips N.V
• Medtronic (Given Imaging)
• NOVARTIS AG
• Olympus Corporation
• Proteus Digital Health Inc.
• Siemens Healthcare GmbH
• Stryker Corporation

ページTOPに戻る

Table of Contents

Table of Contents

1.0 Executive Summary
2.0 Introduction
2.1 Smart Pills Concept
2.1.1 Ingestible Sensors
2.1.2 Smart Pills Components
2.2 Smart Pills Growth Factors and Challenges
2.2.1 Smart Pill Growth Factors
2.2.2 Threat of Substitute Products
2.3 Smart Pills Clinical Trials
2.3.1 Phase 0 Trial
2.3.2 Phase I Trial
2.3.3 Phase II Trial
2.3.4 Phase III Trial
2.3.5 Phase IV Trial
2.3.6 MAMS Trial
2.4 Smart Pills Patents and Investment Trends
2.5 Target Diseases and Disorders
2.6 Regulatory Framework
2.6.1 ISO Standards
2.6.1.1 ISO 27799:2008 and ISO/TR 27809:2007
2.6.1.2 ISO/IEC 27002
2.6.1.3 ISO/TC 215
2.6.2 CEN/TC 251
2.6.3 Health Insurance Portability and Accountability Act (HIPAA)
2.6.3.1 HIPAA Privacy Rule
2.6.3.2 HIPAA Security Rule
2.6.3.3 HIPAA Identifiers Rule
2.6.3.4 HIPAA Enforcement Rule
2.6.4 HITECH Act
2.6.5 European Standard Regulation
2.6.5.1 CEN ISO/IEEE 11073
2.6.5.2 CEN / Cenelec
2.6.5.3 ETSI
2.6.6 Patient Protection and Affordable Care Act
2.6.7 Food and Drug Administration Safety and Innovation Act
2.6.8 The MedTech Act
2.7 Smart Pills Research Landscape
2.8 Competitive Landscape
2.9 Smart Pills Consumer Analysis and Buying Criteria
3.0 Smart Pill Technology and Application Analysis
3.1 Smart Pill Containerization
3.2 Smart Pills for Capsule Endoscopy
3.2.1 Small Bowel Capsule Endoscope
3.2.2 Colon Capsule Endoscope
3.2.3 Esophagus Capsule Endoscope
3.3 Video Capsule Endoscopy
3.4 Gastrointestinal Monitoring Technology
3.5 Workstations and Data Recorders
3.5.1 Wireless Capsule Endoscopy System
3.5.2 Data Storage and Analytics
3.6 Role of AI Technology
3.7 Microchip Technology
3.8 Smart Pills for Drug Delivery
3.9 Patient Monitoring System
3.10 Medical Diagnostic Imaging and Radiology
3.11 3D Printed Ingestible Pills
3.12 Internet of Healthcare Things
4.0 Smart Pill Company Analysis
4.1 Cerner Corporation
4.2 GE Healthcare
4.3 Proteus Digital Health Inc.
4.4 Boston Scientific Corporation
4.5 Medtronic (Given Imaging)
4.6 Koninklijke Philips N.V
4.7 AdhereTech Inc.
4.8 CapsoVision Inc.
4.9 Fujifilm Holdings Corporation
4.10 Bio-Images Drug Delivery (BDD) Limited
4.11 HOYA Corporation (Pentax Medical and Wassenburg Medical)
4.12 Olympus Corporation
4.13 Jinshan Science & Technology (Group) Co. Ltd.
4.14 Siemens Healthcare GmbH
4.15 NOVARTIS AG
4.16 IntroMedic Co. Ltd.
4.17 Stryker Corporation
5.0 Smart Pills Market Analysis and Forecasts 2021 - 2026
5.1 Global Smart Pills Market 2021 - 2026
5.2 Global Smart Pills Market by Pills, Tools and Technologies
5.2.1 Global Smart Ingestible Pills Market by Type
5.2.1.1 Global Smart Ingestible Pills Market by Product Type
5.2.1.2 Global 3D Printed Smart Ingestible Pills Market
5.2.1.3 Global Smart Ingestible Pills Market by Component Type
5.2.1.4 Global Smart Ingestible Pills Market by Distribution Channel
5.2.2 Global Smart Pills Market by Technology and Tools Type
5.2.2.1 Global Smart Pills Market by Capsule Endoscopy Technology Type
5.2.2.1.1 Global Smart Pills Technology Market by Capsule Endoscope Type
5.2.2.1.2 Global Smart Pills Market by Video Capsule Endoscopy Technology
5.2.2.1.3 Global Smart Pills Technology Market by Workstations and Recorders Type
5.2.2.2 Global Smart Pills Market by Gastrointestinal Monitoring Technology Type
5.2.2.3 Global Smart Pills Market by Data Storage and Analytics Software Type
5.2.2.4 Global Smart Pills Market by AI Enabled Data Storage and Analytics Software
5.2.2.4.1 Global Smart Pills Data Storage and Analytics Software Market by AI Technology
5.2.2.5 Global Smart Pills Technology Market by Disease Indication Type
5.2.2.6 Global Smart Pills Technology Market by Distribution Channel
5.3 Global Smart Pills Market by Application Type
5.4 Global Smart Pills Market by Region
5.4.1 North America Smart Pills Market by Product, Technology, Component, End User, Application, and Country
5.4.2 Europe Smart Pills Market by Product, Technology, Component, End User, Application, and Country
5.4.3 APAC Smart Pills Market by Product, Technology, Component, End User, Application, and Country
5.4.4 Latin America Smart Pills Market by Product, Technology, Component, End User, Application, and Country
5.4.5 Middle East and Africa Smart Pills Market by Product, Technology, Component, End User, Application, and Country
6.0 Conclusions and Recommendations
6.1 Advertisers and Media Companies
6.2 Artificial Intelligence Providers
6.3 Smart Pills Providers
6.4 Broadband Infrastructure Providers
6.5 Communication Service Providers
6.6 Computing Companies
6.7 Data Analytics Providers
6.8 Medical Device and Equipment Providers
6.9 Networking Equipment Providers
6.10 Networking Security Providers
6.11 Semiconductor Companies
6.12 IoHT Suppliers and Service Providers
6.13 Software Providers
6.14 Smart City System Integrators
6.15 Pharmaceuticals, Hospitals, and Clinics
6.16 Smart Workplace Solution Providers
7.0 Appendix
7.1 Global IoT Healthcare Connected Device Deployment 2021 - 2026
7.1.1 Global IoT Healthcare Connected Device Deployment by Organization Type
7.1.2 Global IoT Healthcare Connected Device Deployment by Application
7.1.2.1 Global IoT Healthcare Connected Device Deployment by Telemedicine Application
7.1.2.2 Global IoT Healthcare Connected Device Deployment by Telemedicine Sector
7.1.3 Global IoT Healthcare Connected Device Deployment by Region
7.1.3.1 North America IoT Healthcare Connected Device Deployment by Country
7.1.3.2 APAC IoT Healthcare Connected Device Deployment by Country
7.1.3.3 Europe IoT Healthcare Connected Device Deployment by Country
7.1.3.4 Latin America IoT Healthcare Connected Device Deployment by Country
7.1.3.5 MEA IoT Healthcare Connected Device Deployment by Country
7.2 Global IoT Healthcare Connected Things Deployment 2021 - 2026
7.2.1 Global IoT Healthcare Connected Things Deployment by Organization Type
7.2.2 Global IoT Healthcare Connected Things Deployment by Application
7.2.2.1 Global IoT Healthcare Connected Things Deployment by Telemedicine Application
7.2.2.2 Global IoT Healthcare Connected Things Deployment by Telemedicine Sector
7.2.3 Global IoT Healthcare Connected Things Deployment by Region
7.2.3.1 North America IoT Healthcare Connected Things Deployment by Country
7.2.3.2 APAC IoT Healthcare Connected Things Deployment by Country
7.2.3.3 Europe IoT Healthcare Connected Things Deployment by Country
7.2.3.4 Latin America IoT Healthcare Connected Things Deployment by Country
7.2.3.5 MEA IoT Healthcare Connected Things Deployment by Country